Benzinga - Wed, 14 Apr 2021 07:08:49 -0400
Benzinga - Tue, 13 Apr 2021 08:44:05 -0400
Benzinga - Tue, 13 Apr 2021 07:50:58 -0400
Benzinga - Tue, 13 Apr 2021 05:18:31 -0400
Benzinga - Mon, 12 Apr 2021 15:08:58 -0400
Benzinga - Mon, 12 Apr 2021 15:00:54 -0400
Benzinga - Mon, 12 Apr 2021 12:45:21 -0400
Benzinga - Mon, 12 Apr 2021 12:32:23 -0400
Benzinga - Mon, 12 Apr 2021 12:00:14 -0400
Benzinga - Mon, 12 Apr 2021 11:47:48 -0400
Benzinga - Mon, 12 Apr 2021 10:54:34 -0400
Benzinga - Mon, 12 Apr 2021 10:13:11 -0400
Benzinga - Mon, 12 Apr 2021 07:08:12 -0400
Benzinga - Tue, 09 Mar 2021 08:24:19 -0400
Benzinga - Tue, 09 Mar 2021 06:03:09 -0400
load more
Sector: Health Care.Industry: Biotechnology
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. It is advancing a deep and sustainable product portfolio of 18 gene therapy product candidates, with exclusive options to acquire four additional development programs. Its product candidates include TSHA-101, TSHA-118, TSHA-102, TSHA-103, and TSHA-104.

Earnings

see more
Q1 2021Est.ActualSurprise
EPS
(EXPECTED)2021-04-27
REV
Q4 2020Est.ActualSurprise
EPS-0.370-1.040 -0.6700
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
TSHATaysha Gene Therapies-2.39%965.6M

Taysha Gene Therapies Company Questions & Answers

Q

How do I buy Taysha Gene Therapies (TSHA) stock?

A

You can purchase shares of Taysha Gene Therapies (NASDAQ: TSHA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Taysha Gene Therapies's (TSHA) main competitors?

A

Other companies in Taysha Gene Therapies’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Syndax Pharmaceuticals (NASDAQ:SNDX) and Humanigen (NASDAQ:HGEN).

Q

What is the target price for Taysha Gene Therapies?

A

The latest price target for Taysha Gene Therapies (NASDAQ: TSHA) was reported by Chardan Capital on 2021-04-13. The analyst firm set a price target for 67.50 expecting TSHA to rise to within 12 months (a possible 163.98% upside). 10 analyst firms have reported ratings in the last year.

Q

How much is Taysha Gene Therapies (TSHA) stock ?

A

The stock price for Taysha Gene Therapies (NASDAQ: TSHA) is $25.57 last updated Today at 8:00:02 PM.

Q

When is the next Taysha Gene Therapies (TSHA) dividend?

A

There are no upcoming dividends for Taysha Gene Therapies.

Q

When is Taysha Gene Therapies (NASDAQ:TSHA) reporting earnings?

A
Taysha Gene Therapies’s Q1 earnings are confirmed after-market from now on April 27, 2021.
Q

When is the upcoming split for TSHA?

A

There is no upcoming split for Taysha Gene Therapies.